• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Immunological Reviews

    Immunological Reviews

    JournalISSN 0105-2896eISSN 1600-065X中科院 医学 2区

    年发文量

    研究主题

    论文(4926)

    排序
    1NewPosttranslational Modifications of Unconventional Autoantigens: Shaping Immunogenicity and Inflammatory Activity
    Roberto Lande,Anna Mennella,Raffaella Palazzo,Loredana Frasca

    ABSTRACT Posttranslational modifications (PTMs) of self‐antigens precipitate autoimmunity by generating neo‐epitopes that breach tolerance and activate autoreactive T and B cells. This review spotlights cathelicidin LL37 and chemokine CXCL4 (PF4) in psoriatic disease (psoriasis and psoriatic arthritis, PSO and PSA), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc), drawing on key studies including our own. Uniquely, unlike most autoantigens, LL37 and CXCL4 exert a dual role: they are immunogenic targets for T and B cells while directly fueling innate inflammation. Through chaperone‐like binding to self‐ and microbial DNA/RNA, they form complexes that potently stimulate plasmacytoid and myeloid dendritic cells (pDCs/mDCs) via DNA/RNA sensors, such as TLR7‐9 and cGAS/STING, driving Type I interferon and cytokines storms. Strikingly, these complexes also induce B cells to become antibody‐producing plasma cells, amplifying adaptive responses and likely suppressing regulation. Here, we detail the role of PTM‐modified LL37 in PSO, PSA, and SLE—forming autoantigenic neutrophil extracellular traps—and CXCL4 in SSc, where it acts as biomarker and autoantibody target. Our work underscores how this dual functionality as “bifunctional autoantigens” exacerbates disease, and how PTMs modification influence these phenomena. These molecules and their PTM can be targeted to halt inflammatory cascades and restore tolerance.

    2026
    引用
    AI阅读
    加入学术空间
    2NewB Cell Subpopulations and Their Functions
    Andrew Getahun
    2026
    引用
    AI阅读
    加入学术空间
    3NewHybrid Insulin Peptides in Type 1 Diabetes: How They Form and Why They Matter
    Kelly Douglas,Thomas Delong

    ABSTRACT Type 1 diabetes is a T cell‐mediated autoimmune disease that leads to the destruction of the insulin‐producing beta cells of the pancreas, yet the antigens that drive this response have been difficult to define. This review traces the identification of hybrid insulin peptides (HIPs), posttranslationally modified autoantigens formed when a fragment of insulin is joined through a peptide bond to a fragment of a second beta cell granule protein, creating a sequence not encoded by any single gene. Beginning with the search for the antigen of the diabetogenic BDC‐2.5 clone in the nonobese diabetic (NOD) mouse, we show that its natural ligand is a hybrid of an insulin C‐peptide fragment and a peptide derived from chromogranin A, and that subsequent mass spectrometry analyses defined a set of disease‐relevant HIPs supported by both T cell reactivity and detection of the endogenous peptide. We summarize the recognition of HIPs by CD4 T cells across several HLA class II alleles in human disease, the enzymatic and nonenzymatic routes of HIP formation within acidic secretory and crinophagic compartments, and genetic evidence that reducing HIP formation delays diabetes. Finally, we propose a multi‐trigger model linking a species difference in HIP formation to the focal, episodic islet pathology of human type 1 diabetes.

    2026
    引用
    AI阅读
    加入学术空间
    4NewOxidative Stress, Post‐Translational Modifications, and Type 1 Diabetes Pathogenesis
    Colleen J. Winstead, Miki Hodel, Hubert M. Tse

    ABSTRACT Type 1 diabetes (T1D) is an organ‐specific autoimmune disease that destroys insulin‐producing beta‐cells. Insulin is a vital hormone for regulating glycemia that often undergoes post‐translational modifications during processing from pre‐proinsulin to biologically active insulin. While necessary for proper glucose homeostasis, insulin is also an autoantigen recognized by autoreactive T cells in T1D. Cellular stress pathways including endoplasmic reticulum stress and oxidative stress mediated by an increase in reactive oxygen species (ROS) synthesis and/or a concomitant decrease in antioxidant function can further drive post‐translational modifications of various autoantigens in T1D including insulin. Innate immune‐derived ROS generation is an essential frontline defense against microbial infections, but ROS can also function as signaling intermediates to properly stimulate T cell responses. Oxidative stress‐induced post‐translational modifications are thought to trigger autoreactive T cells in T1D by generating novel neoepitopes, eliciting epitope spreading, or enhancing autoantigen interactions with antigen‐presenting cells. With the current technology, detecting post‐translationally modified proteins is challenging. In this review, we will explore the role of ROS and other post‐translational modifications involved in T1D. We will also discuss islet transplantation strategies being used for patients with T1D including novel cell sources for beta‐cell replacement and management of oxidative stress after transplantation.

    2026
    引用
    AI阅读
    加入学术空间
    5NewEntering the Age of Specificity in T Cell Immunity
    Paul G. Thomas

    ABSTRACT The discovery of MHC restriction, the resolution of peptide–MHC structure, and the identification of the T cell receptor gene quickly centered epitope‐level specificity as a core concern of T cell biology. Epitope mapping culminated in functional peptide‐based stimulation assays and tetramer staining, which together provide exquisite resolution of individual responses. Despite these tools, quantitative assessment of epitope‐resolved responses in complex human infections and tumors has rarely been applied at scale. As a result, no epitope‐aware correlates of protection or risk have been established for major infections, and most human T cell profiling still occurs at the level of representative epitopes or bulk assays. In this review, I propose that variation in specificity, defined as distinct epitope‐level responses across individuals, represents a largely untested critical element in our assessment of anti‐pathogen and antitumor immunity. Advances in TCR repertoire profiling and reverse epitope discovery now make formal tests of this hypothesis tractable, and I discuss approaches to determine the extent to which epitope variation underlies the noise and variation of human immune phenotypes.

    2026引用:1
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 4926 篇论文

    高被引作者

    作者引用发文
    Shimon Sakaguchi47606
    Takashi Nomura46173
    Arlene Sharpe43186
    Thirumala-Devi Kanneganti41329
    Jeffrey Bluestone393813
    Peter T. Sage34082
    Charles Janeway Jr.33788
    Megan Levings32895
    Leonard A. Herzenberg32154
    Maria Grazia Roncarolo32046

    高产作者

    作者引用发文
    Antonio Coutinho275620
    Jonathan Sprent231518
    Rolf Zinkernagel220916
    Philippa Marrack271116
    John W. Kappler267415
    Tomohiro Kurosaki76815
    Emil Raphael Unanue176813
    Jeffrey Bluestone393813
    Harald Von Boehmer126313
    Guido Kroemer136513

    相关期刊

    Seminars in Immunology
    Journal of leukocyte biology
    Trends in Immunology
    Clinical & translational immunology
    Science immunology
    Annual Review of Immunology
    Nature Immunology
    European Journal Of Immunology
    Cellular Immunology
    Immunology Letters